-
1
-
-
63149133956
-
International tables of glycemic index and glycemic load values
-
Atkinson F.S., Foster-Powell K., Brand-Miller J.C. International tables of glycemic index and glycemic load values. Diabetes Care 2008, 31:2281-2283.
-
(2008)
Diabetes Care
, vol.31
, pp. 2281-2283
-
-
Atkinson, F.S.1
Foster-Powell, K.2
Brand-Miller, J.C.3
-
2
-
-
0032902850
-
The relationship between glucose and incident cardiovascular events. A meta regression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years
-
Coutinho M., Gerstein H.C., Wang Y., Yusuf S. The relationship between glucose and incident cardiovascular events. A meta regression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years. Diabetes Care 1999, 22:233-234.
-
(1999)
Diabetes Care
, vol.22
, pp. 233-234
-
-
Coutinho, M.1
Gerstein, H.C.2
Wang, Y.3
Yusuf, S.4
-
3
-
-
0035847591
-
The DECODE Study Group Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria
-
The DECODE Study Group Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria. Arch Intern Med 2001, 161:397-405.
-
(2001)
Arch Intern Med
, vol.161
, pp. 397-405
-
-
-
4
-
-
18144415490
-
Should minimal blood glucose variability become the gold standard of glycemic control?
-
Hirsch I.B., Brownlee M. Should minimal blood glucose variability become the gold standard of glycemic control?. J Diabet Complications 2005, 19:178-181.
-
(2005)
J Diabet Complications
, vol.19
, pp. 178-181
-
-
Hirsch, I.B.1
Brownlee, M.2
-
5
-
-
0037421492
-
Role of oxidative stress in atherosclerosis
-
Harrison D., Griendling K.K., Landmesser U., Hornig B., Drexler H. Role of oxidative stress in atherosclerosis. Am J Cardiol 2003, 91:7A-11A.
-
(2003)
Am J Cardiol
, vol.91
-
-
Harrison, D.1
Griendling, K.K.2
Landmesser, U.3
Hornig, B.4
Drexler, H.5
-
6
-
-
0034083227
-
Role of oxidative stress in cardiovascular disease
-
Dhalla N.S., Temsah R.M., Netticadan T. Role of oxidative stress in cardiovascular disease. J Hypertens 2000, 18:655-673.
-
(2000)
J Hypertens
, vol.18
, pp. 655-673
-
-
Dhalla, N.S.1
Temsah, R.M.2
Netticadan, T.3
-
7
-
-
9644303202
-
Postprandial glucose response to Chinese foods in patients with type 2 diabetes
-
Chan E.M., Cheng W.M., Tiu S.C., Wong L.L. Postprandial glucose response to Chinese foods in patients with type 2 diabetes. J Am Diet Assoc 2004, 104:1854-1858.
-
(2004)
J Am Diet Assoc
, vol.104
, pp. 1854-1858
-
-
Chan, E.M.1
Cheng, W.M.2
Tiu, S.C.3
Wong, L.L.4
-
8
-
-
0037339148
-
Effect of altering gastric emptying on postprandial plasma glucose concentrations following a physiologic meal in type-II diabetic patients
-
Gonlachanvit S., Hsu C.W., Boden G.H., Knigh L.C., Maurer A.H., Fisher R.S., et al. Effect of altering gastric emptying on postprandial plasma glucose concentrations following a physiologic meal in type-II diabetic patients. Dig Dis Sci 2003, 48:488-497.
-
(2003)
Dig Dis Sci
, vol.48
, pp. 488-497
-
-
Gonlachanvit, S.1
Hsu, C.W.2
Boden, G.H.3
Knigh, L.C.4
Maurer, A.H.5
Fisher, R.S.6
-
9
-
-
0029609776
-
The mechanism of alpha-glucosidase inhibition in the management of diabetes
-
Bischoff H. The mechanism of alpha-glucosidase inhibition in the management of diabetes. Clin Invest Med 1995, 18:303311.
-
(1995)
Clin Invest Med
, vol.18
, pp. 303311
-
-
Bischoff, H.1
-
10
-
-
35548994949
-
Cardiovascular benefits and safety profile of acarbose therapy in prediabetes and established type 2 diabetes
-
Markolf H. Cardiovascular benefits and safety profile of acarbose therapy in prediabetes and established type 2 diabetes. Cardiovasc Diabetol 2007, 6:20.
-
(2007)
Cardiovasc Diabetol
, vol.6
, pp. 20
-
-
Markolf, H.1
-
11
-
-
0038455703
-
Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial
-
Chiasson J.L., Josse R.G., Gomis R., Hanefeld M., Karasik A., Laakso M. Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial. JAMA 2003, 290:486-494.
-
(2003)
JAMA
, vol.290
, pp. 486-494
-
-
Chiasson, J.L.1
Josse, R.G.2
Gomis, R.3
Hanefeld, M.4
Karasik, A.5
Laakso, M.6
-
12
-
-
0346727578
-
Acarbose reduces the risk for myocardial infarction in type 2 diabetic patients: meta-analysis of seven long-term studies
-
Hanefeld M., Cagatay M., Petrowitsch T., Neuser D., Petzinna D., Rupp M. Acarbose reduces the risk for myocardial infarction in type 2 diabetic patients: meta-analysis of seven long-term studies. Eur Heart J 2004, 25:10-16.
-
(2004)
Eur Heart J
, vol.25
, pp. 10-16
-
-
Hanefeld, M.1
Cagatay, M.2
Petrowitsch, T.3
Neuser, D.4
Petzinna, D.5
Rupp, M.6
|